These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32095079)

  • 21. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
    Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related.
    Nguyen HB; Le XT; Nguyen HH; Vo TT; Le MK; Nguyen NT; Do-Nguyen TM; Truong-Nguyen CM; Nguyen BT
    Cancer Inform; 2022; 21():11769351221100730. PubMed ID: 35614962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
    Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.
    Li C; Zhang Z; Zhang P; Liu J
    Hepatol Res; 2014 Oct; 44(10):E11-25. PubMed ID: 23834468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
    Hussein TD
    Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
    Marrero JA; Feng Z; Wang Y; Nguyen MH; Befeler AS; Roberts LR; Reddy KR; Harnois D; Llovet JM; Normolle D; Dalhgren J; Chia D; Lok AS; Wagner PD; Srivastava S; Schwartz M
    Gastroenterology; 2009 Jul; 137(1):110-8. PubMed ID: 19362088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma.
    Ali OM; El Amin HA; Sharkawy YL; Mohamed Ali AA; Kholef EFM; Elsewify WAE
    Int J Gen Med; 2020; 13():193-200. PubMed ID: 32547160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers.
    He L; Zhang C; Liu LL; Huang LP; Lu WJ; Zhang YY; Zou DY; Wang YF; Zhang Q; Yang XL
    World J Gastrointest Oncol; 2024 Jun; 16(6):2463-2475. PubMed ID: 38994169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.
    Yao S; Zhang J; Chen H; Sheng Y; Zhang X; Liu Z; Zhang C
    J Histochem Cytochem; 2013 Sep; 61(9):639-48. PubMed ID: 23686365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
    Jeon Y; Jang ES; Choi YS; Kim JW; Jeong SH
    Clin Mol Hepatol; 2016 Sep; 22(3):359-365. PubMed ID: 27729630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers.
    Burciu C; Șirli R; Bende R; Popa A; Vuletici D; Miuțescu B; Rațiu I; Popescu A; Sporea I; Dănilă M
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
    Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
    Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
    Chen J; Tang D; Xu C; Niu Z; Li H; Li Y; Zhang P
    Lab Med; 2021 Jul; 52(4):381-389. PubMed ID: 33159511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy.
    Zhu Q; Zhou J; Li H; Wang H; Ren J; Sun S; Yang M; Wu S; Cao M; Wang K; You H; Ma H
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12691-12701. PubMed ID: 37452848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhou Y; Yin X; Ying J; Zhang B
    BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3.
    Volk ML; Hernandez JC; Su GL; Lok AS; Marrero JA
    Cancer Biomark; 2007; 3(2):79-87. PubMed ID: 17522429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
    Caviglia GP; Abate ML; Petrini E; Gaia S; Rizzetto M; Smedile A
    Hepatol Res; 2016 Mar; 46(3):E130-5. PubMed ID: 26082262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer.
    Kang Z; Jin K; Jing J
    Dis Markers; 2022; 2022():8640999. PubMed ID: 36277979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.